secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACACIA RESEARCH CORP (ACTG)
CIK:        0000934549
Form:       8-K
Filed at:   2022-08-11T23:59:59+00:00
Accession:  0000934549-22-000041
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acacia Research Q2 net loss $61.5M; revenue $16.7M; special committee to review Starboard deal
--------------------------------------------------------------------------------

- GAAP net loss of $61.5M ($1.44/sh) vs net income of $19.7M ($0.23/sh) in Q2 2021.
- Total revenue $16.7M (IP $8.1M, Industrial $8.7M) down from $17.4M; operating loss $5.7M.
- Repaid $50M of Starboard notes in Q2 and $55M post-quarter; completed $40M share buyback (6.1M shares at avg $4.64).
- Realized gains $11.5M; unrealized losses $57.6M; $26.7M milestone from Mycovia FDA approval expected later in 2022.
- Board formed special committee to review Starboard relationship; pro forma book value $5.87/sh.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/934549/000093454922000041/0000934549-22-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/934549/000093454922000041/actg-20220811.htm
  HTML page:      https://secwatch.observer/filing/0000934549-22-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer